ArticleCancer research communications2024

Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis.

Jack Pengfei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.